not differ from men in Symptom scores on the SGRQ but differed markedly on the Background -There is some evidence that Activity and Impact scales.
related to nebuliser provision. Women did randomised trial of a three month rehabilitation patients with COPD by contacting wards (in the respiratory unit and eight non-respiratory units) after their receiving days. From hospital computer records 478 patients had a primary discharge diagnosis of COPD during the study, remaining 377 (79%) patients were identified for the study during their stay in hospital, 266 of whom completed the SGRQ (61 patients refused the interview, 12 were unable to be interviewed because of deafness (7) or conprogramme for 88 patients with COPD and fusion (5), and 38 patients died during their asthma, all of whom seemed to show excessive admission and were excluded from the analysis; impairment for their level of pulmonary functable 1). This non-interviewed group also did tion in terms of hospital admissions and days not differ from those studied in pulmonary of inactivity. He followed these patients for two function, age, or outcome over the following years and found that initial improvement in 12 months. Data were collected from patient pulmonary function in the intervention group notes on spirometric indices, provision of newas not maintained in the long term, but imbuliser and domiciliary oxygen before adprovement in "experienced invalidity" was mission and at discharge, and follow up after maintained over two years with an accompanydischarge. After one year all case records were ing significant reduction in days in hospital for re-examined for re-admissions and deaths. the intervention patients.
Methods
The SGRQ contains 76 items which ask From these studies it appears that poor QOL patients to review the past 12 months for fremay be related to a greater likelihood of adquency of respiratory symptoms, impact or mission to hospital. If QOL is related to risk distress caused to them by symptoms, and of hospitalisation, then bringing about change limitations of activity because of symptoms. in QOL, even without associated physiological Answers to SGRQ items are weighted and total change, may have important consequences for SGRQ score and scores on the three subscales effective use of resources. Ketelaars et al 12 have (Symptom frequency, Impact, and Activity) are recently shown that scores on the SGRQ are calculated by adding these weights. 17 Scores related to "coping strategies" of patients with are then converted to percentages by dividing COPD, with those who use a coping strategy of the weighted score obtained by the total posavoidance or denial having better QOL scores. sible weighted score. The higher the score the As part of an audit of inpatient care of poorer the quality of life. A difference of 4% patients with chronic respiratory disease we is taken to be clinically significant on the total decided to included a QOL measure which or subscales. 17 The results of the SGRQ were would allow us to test whether those patients not made known to doctors during the study. who had worse QOL were at greater risk of Statistical analysis was carried out using being admitted again in the next 12 months. SPSS-PC. SGRQ scores were normally disNebuliser provision is also likely to reflect the tributed and t tests were used to compare group impact of illness on daily activities and distress means. Spearman correlation coefficients were of patients, so we decided to investigate whether calculated. Logistic regression was used to this related to patient QOL. Review of the establish odds ratios for re-admission and neliterature suggested that the SGRQ was a valbuliser provision, adjusting for age, sex, and idated QOL measure which would be easy to lung function (where patients did not have administer and score. We therefore carried out spirometric results mean substitution was a study to see if scores on this QOL measure used). would be associated with clinical outcomes and use of resources. Table 4 shows differences in total SGRQ capacity (FVC) was 58.9 (23.8)% predicted. scores and scores for the three subscales beThe mean (SD) SGRQ score was 52.7 (13.1), tween those re-admitted (and/or died from range 10.9-80.5 (table 2) .
Results

The mean (SD) age of the 266 patients was
COPD related causes) and those not re-adSeventeen patients were admitted to hospital mitted. Both the total SGRQ score and the and died from COPD in the 12 months fol-subscale scores were significantly different belowing the audit. There was no significant tween the two groups, with differences ranging difference in SGRQ score between these from 3.3 to 5.6. The largest difference (5.6) patients and those re-admitted for COPD who was in the Impact subscale which measures the survived for 12 months (difference=1.1, 95% distress caused to patients by their condition. CI −5.0 to 7.3, p=0.7). These 17 deaths from Neither FEV 1 nor FVC distinguished between COPD were grouped with the 92 COPD re-re-admissions and those not readmitted. Age, admissions as "re-admitted for COPD or sex, and current smoking status did not relate COPD death in 12 months". Another 23 to risk of re-admission. patients either died from non-COPD causes One hundred patients (42%) had home ne-(five cardiac failure, three carcinomas, one bulisers before coming into hospital and congastrointestinal haemorrhage) or died without tinued with their use after returning home. a hospital re-admission in the following 12 These patients had significantly worse SGRQ months and with no stated cause of death in scores (56.9 versus 51.2, 95% CI 2.5 to 8.8). their notes. These patients had a better score Of the 138 patients without a nebuliser on on the SGRQ than all other groups (differ-entry, 14 were prescribed a nebuliser at disence=7.4, 95% CI 1.5 to 13.4, p=0.01). For charge. Provision of a home nebuliser at discharge was significantly related to total SGRQ score (p<0.001) and to the Impact and Activity subscales showed that symptoms did not vary * * p<0.01.
with age but QOL impact was significantly greater for younger patients (table 5) . Women also reported more impact and restriction of poorly related to re-admission to hospital or nebuliser provision. The Activity scores did * Odds ratios show the effect of a five point change on each scale.
show that significant differences in self per- 1 Adjusted for age, % predicted FEV 1 and FVC, sex, and ceived activity limitation exist between men nebuliser provision (at discharge and before entry to hospital). 2 Adjusted for age, % predicted FEV 1 and FVC, and sex. and women and older and younger patients. 3 Mean substitution was used for the 70 cases where no spiroWomen with COPD feel they are more limited metric data were available.
in activities than do men, and women experience greater distress from their illness without reporting any worse levels of symptoms. for effects of age, sex, and lung function. For adjusted odds ratios, Symptoms, Impact and The patients who were relatively younger also showed most signs of suffering from the psyActivity were all significantly related to readmission and Impact was also related to ne-chological impact of their disease. The greater distress caused by COPD to these groups has buliser provision (table 7) .
Over the 12 months following the audit 55% been previously reported. 18 Patients with a home nebuliser were more of patients with nebulisers were re-admitted compared with 45% of patients without ne-likely to be re-admitted to hospital over the following 12 months but when we controlled for bulisers (p<0.01). This difference was no longer significant when SGRQ score was con-SGRQ score the relationship between nebuliser and re-admission was no longer significant, trolled for in a logistic regression analysis.
Patients in the care of respiratory physicians showing that the greater number of admissions among patients with a home nebuliser was did not differ in Symptom QOL but had worse Impact QOL (difference=4.4, p=0.03) and unlikely to be due to the provision of a nebuliser per se. This illustrates how a valid QOL measworse Activity QOL (difference=3.2, p=0.05) and were more likely to be re-admitted (53% ure can be used to correct for differences between patients when investigating differences versus 40%, p<0.05).
in outcome. Assessing patient coping and the impact of disease on patients is a normal part of the Discussion These results show that patients with poor clinical interview and it is not surprising that poor quality of life should be related to de-QOL are at greater risk of hospital re-admission after an initial admission and that patients are cisions to admit to hospital or to provide support such as home nebulisers. QOL measures also more likely to be provided with home nebulisers if they have poor QOL. The results can reflect this clinical assessment, but at present such scales do not have great enough sensialso suggest that patients are likely to be referred to respiratory specialists if they have tivity to be used as determinants of clinical decisions. Guyatt, however, found that patients poor QOL. We did not find that percentage predicted FEV 1 or FVC was related to re-were more reluctant to volunteer information about the emotional impact of illness 19 than admission within 12 months among this group of patients. The results of this study suggest about symptoms, and he has suggested that QOL scales should provide a way of eliciting that, in patients whose range of lung function is restricted, differences in QOL are more sig-areas of distress for patients.
Poor QOL in patients with COPD has prenificantly related to clinical decisions and use of resources than are differences in pulmonary viously been linked to greater use of health resources 14 and the study by Cox et al 16 suggests function.
QOL scales are designed to measure psy-that, when QOL improves, even though lung function does not, consultations and hospital chological impact and subjective experience of patients, but all QOL scales also have a symp-admissions decrease. The results of our study are compatible with those of Cox et al in showtom component. It might be the symptom measure component of the total score which ing that poor QOL is associated with a greater chance of admission and of nebuliser provision. predicts risk of admission to hospital rather than the more subjective components meas-Thus QOL outcomes, even when there is no physiological improvement, may be important uring distress and daily life limitation. Because the SGRQ provides separate subscale scores in assessing the success of interventions in patients with COPD. The SGRQ appears to for Symptoms, Impact and Activity we were able to test which aspects of QOL best dis-distinguish patients who cope relatively well, despite having high symptom levels, and to criminated differences in outcome between patients. Although all scales showed differences show that this good coping has clinical con- 
